Identification of a circulating microvesicle protein network involved in ST-elevation myocardial infarction

Area of Science:

• Cardiovascular Proteomics
• Intercellular Communication
• Biomarker Discovery

Background:

• Membrane microvesicles (MVs) are released from activated cells, particularly platelets, into circulation.
• Increased MV levels are observed in acute coronary syndromes, highlighting their role in cardiovascular disease.
• Understanding MV composition is crucial for identifying disease mechanisms and therapeutic targets.

Purpose of the Study:

• To perform a differential proteomic analysis of plasma MVs from ST-elevation myocardial infarction (STEMI) patients and stable coronary artery disease (SCAD) controls.
• To identify potential MV biomarkers and drug targets relevant to the pathogenesis of acute myocardial infarction.
• To explore protein-protein interactions and their association with disease using a systems biology approach.

Main Methods:

• Differential proteomic analysis using 2D-DIGE and mass spectrometry.
• Validation of identified proteins via western blotting in an independent patient cohort.
• Systems biology analysis to predict protein-protein interactions and disease relevance.

Main Results:

• 117 protein features varied significantly between STEMI and SCAD groups (fold change ≥2; p<0.01).
• 102 proteins were identified, with most involved in inflammatory response and cardiovascular disease; 11 related to infarction.
• Up-regulation of α2-macroglobulin isoforms, fibrinogen, and viperin observed in MVs from STEMI patients; several proteins linked to thrombogenesis.

Conclusions:

• Plasma MVs from STEMI patients exhibit a unique proteomic signature compared to SCAD patients.
• Identified proteins, including α2-macroglobulin and fibrinogen, are implicated in thrombogenesis and myocardial infarction.
• This study provides a promising panel of proteins from MVs as potential biomarkers and drug targets for myocardial infarction.